(Novo Nordisk) is a Delaware corporation, which has its principal place of business at 800 Scudders Mill Road, Plainsboro, NJ 08536
Ahrn B, Masmiquel L, Kumar H et al (2017) Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial
Gradually increasing the dose helps to reduce these side effects
Its GLP-1 options include Ozempic, Saxenda, and Wegovy
Zudem kehrten auch die positiven Vernderungen in den kardiometabolischen Risikofaktoren, wie Blutdruck, Blutfette, HbA1c und C-reaktives Protein, in hnlicher Weise zurck
But unlike Novo Nordisk's pill, Eli Lilly's treatment is not a peptide medication